Company intelligence / Profile preview

Calibra Medical

Redwood City, California, United Statesprnewswire.com ↗

Ownership: Private
Development stage: Commercial

Overview

Calibra Medical developed the Finesse/OneTouch Via wearable insulin patch for discreet mealtime insulin delivery. The product was designed to improve adherence and simplify therapy for people with type 1 and type 2 diabetes. The system allowed on-demand bolus dosing through clothing and held a three-day supply of rapid acting insulin. Clinical results focused on usability, safety, and patient satisfaction rather than traditional drug efficacy endpoints.

Therapeutic areas: Endocrinology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Johnson & Johnson Diabetes Care CompaniesCeQur

Beyond the preview

Go deeper on Calibra Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calibra Medical.

Explore the full profile